These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18580585)

  • 1. Revising the ADAS-cog for a more accurate assessment of cognitive impairment.
    Wouters H; van Gool WA; Schmand B; Lindeboom R
    Alzheimer Dis Assoc Disord; 2008; 22(3):236-44. PubMed ID: 18580585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
    Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
    Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The characteristics of patients with uncertain/mild cognitive impairment on the Alzheimer disease assessment scale-cognitive subscale.
    Pyo G; Elble RJ; Ala T; Markwell SJ
    Alzheimer Dis Assoc Disord; 2006; 20(1):16-22. PubMed ID: 16493231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues.
    Perneczky R; Pohl C; Sorg C; Hartmann J; Komossa K; Alexopoulos P; Wagenpfeil S; Kurz A
    Age Ageing; 2006 May; 35(3):240-5. PubMed ID: 16513677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls.
    Graham DP; Cully JA; Snow AL; Massman P; Doody R
    Alzheimer Dis Assoc Disord; 2004; 18(4):236-40. PubMed ID: 15592137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gaining precision on the Alzheimer's Disease Assessment Scale-cognitive: a comparison of item response theory-based scores and total scores.
    Balsis S; Unger AA; Benge JF; Geraci L; Doody RS
    Alzheimers Dement; 2012 Jul; 8(4):288-94. PubMed ID: 22465173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease.
    Rozzini L; Vicini Chilovi B; Bertoletti E; Conti M; Delrio I; Trabucchi M; Padovani A
    J Geriatr Psychiatry Neurol; 2008 Dec; 21(4):261-7. PubMed ID: 19017783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer?
    Vellas B; Andrieu S; Cantet C; Dartigues JF; Gauthier S
    J Nutr Health Aging; 2007; 11(4):338-41. PubMed ID: 17653494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the reliability of ADAS-Cog change scores.
    Grochowalski JH; Liu Y; Siedlecki KL
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2016 Sep; 23(5):513-29. PubMed ID: 26708116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID).
    Verhey FR; Houx P; Van Lang N; Huppert F; Stoppe G; Saerens J; Böhm P; De Vreese L; Nordlund A; DeDeyn PP; Neri M; Peña-Casanova J; Wallin A; Bollen E; Middelkoop H; Nargeot MC; Puel M; Fleischmann UM; Jolles J
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):41-50. PubMed ID: 14716698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the accuracy and precision of cognitive testing in mild dementia.
    Wouters H; Appels B; van der Flier WM; van Campen J; Klein M; Zwinderman AH; Schmand B; van Gool WA; Scheltens P; Lindeboom R
    J Int Neuropsychol Soc; 2012 Mar; 18(2):314-22. PubMed ID: 22206624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NIH stroke scale can establish cognitive function after stroke.
    Cumming TB; Blomstrand C; Bernhardt J; Linden T
    Cerebrovasc Dis; 2010; 30(1):7-14. PubMed ID: 20424439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAS-cog (Alzheimer's Disease Assessment Scale-cognitive subscale)--validation of the Slovak version.
    Kolibas E; Korinkova V; Novotny V; Vajdickova K; Hunakova D
    Bratisl Lek Listy; 2000; 101(11):598-602. PubMed ID: 11218956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory.
    Hobart J; Cano S; Posner H; Selnes O; Stern Y; Thomas R; Zajicek J;
    Alzheimers Dement; 2013 Feb; 9(1 Suppl):S10-20. PubMed ID: 23253779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Shortened version of the Barcelona test (III): criterion validity with the ADAS-Cog].
    Peña-Casanova J; Meza M; Bertran-Serra I; Manero RM; Espel G; Martí A; Böhm P; Blesa R; Guardia J
    Neurologia; 1997 Mar; 12(3):117-9. PubMed ID: 9198452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three sides of the same coin: measuring global cognitive impairment with the MMSE, ADAS-cog and CAMCOG.
    Wouters H; van Gool WA; Schmand B; Zwinderman AH; Lindeboom R
    Int J Geriatr Psychiatry; 2010 Aug; 25(8):770-9. PubMed ID: 19946861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation of a new ADAS-cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer disease.
    Llano DA; Laforet G; Devanarayan V;
    Alzheimer Dis Assoc Disord; 2011; 25(1):73-84. PubMed ID: 20847637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer disease.
    Sano M; Raman R; Emond J; Thomas RG; Petersen R; Schneider LS; Aisen PS
    Alzheimer Dis Assoc Disord; 2011; 25(2):122-7. PubMed ID: 20921876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Errors in ADAS-cog administration and scoring may undermine clinical trials results.
    Schafer K; De Santi S; Schneider LS
    Curr Alzheimer Res; 2011 Jun; 8(4):373-6. PubMed ID: 21557720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adaptation and normalization of the Alzheimer's disease Assessment Scale for Spain (NORMACODEM) (II)].
    Peña-Casanova J; Aguilar M; Santacruz P; Bertran-Serra I; Hernández G; Sol JM; Pujol A; Blesa R
    Neurologia; 1997 Feb; 12(2):69-77. PubMed ID: 9147454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.